Position in TMO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$758,647,924
-$50,896,578 QoQ
Shares Held
1,513,180
-8.1% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#45
of 2,606 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Nuveen, LLC holds $3,139,006,046 across 30 Diagnostics & Research names. TMO ranks #2 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
5,242,679 | $998,625,494 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
1,513,180 | $758,647,924 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
484,519 | $255,070,180 | |
| 4 | NTRA |
Natera, Inc.
|
499,089 | $135,477,707 | |
| 5 | DGX |
Quest Diagnostics Inc
|
563,830 | $119,503,766 | |
| 6 | WAT |
Waters Corp /De/
|
290,613 | $108,991,497 | |
| 7 | A |
Agilent Technologies, Inc.
|
782,694 | $103,965,242 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
487,108 | $94,119,005 |
All Filings in TMO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $758,647,924 | 1,513,180 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $809,544,502 | 1,646,989 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $1,244,250,666 | 2,147,296 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $631,100,748 | 1,301,185 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $474,880,833 | 1,171,215 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $532,360,345 | 1,069,856 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||